BR9909153A - Voacamine as an antimalarial agent, and antimalarial agent that contains voacamine - Google Patents

Voacamine as an antimalarial agent, and antimalarial agent that contains voacamine

Info

Publication number
BR9909153A
BR9909153A BR9909153-4A BR9909153A BR9909153A BR 9909153 A BR9909153 A BR 9909153A BR 9909153 A BR9909153 A BR 9909153A BR 9909153 A BR9909153 A BR 9909153A
Authority
BR
Brazil
Prior art keywords
voacamine
agent
antimalarial agent
antimalarial
pescheria
Prior art date
Application number
BR9909153-4A
Other languages
Portuguese (pt)
Inventor
Silvio Rossi
Guiseppe Bertelli Motta
Original Assignee
Millenia Hope Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millenia Hope Inc filed Critical Millenia Hope Inc
Publication of BR9909153A publication Critical patent/BR9909153A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

<B>VOACAMINA COMO UM AGENTE ANTIMALáRIA, E AGENTE ANTIMALáRIA QUE CONTéM VOACAMINA<D>, mais particularmente a invenção refere-se à voacamina como um agente ativo antimalária contra cepas de Plasmodium falciparum, incluindo as cepas resistentes, vem como um agente antimalária que contém como princípio ativo principal a voacamina. Um extrato de Pescheria básico, particularmente Pescheria Fuchsiaefolia, pode ser utilizado como agente antimalária contendo particularmente a voacamina como princípio ativo.<B> VOACAMINE AS AN ANTIMALARY AGENT, AND ANTI-MALARIA AGENT CONTAINING VOACAMINE <D>, more particularly the invention refers to voacamine as an active antimalarial agent against Plasmodium falciparum strains, including resistant strains, comes as an antimalarial agent that contains voacamine as its main active ingredient. A basic Pescheria extract, particularly Pescheria Fuchsiaefolia, can be used as an anti-malarial agent, particularly containing voacamine as an active ingredient.

BR9909153-4A 1998-03-26 1999-03-25 Voacamine as an antimalarial agent, and antimalarial agent that contains voacamine BR9909153A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98TO000264A ITTO980264A1 (en) 1998-03-26 1998-03-26 APPLICATION OF A NON-QUATERNARY BASIC EXTRACT OF FUCHSIAEFOLIA PESCHIERA WITH ANTI-MALARICA ACTIVITY
IT9990052 1999-03-25

Publications (1)

Publication Number Publication Date
BR9909153A true BR9909153A (en) 2000-11-14

Family

ID=11416637

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909153-4A BR9909153A (en) 1998-03-26 1999-03-25 Voacamine as an antimalarial agent, and antimalarial agent that contains voacamine

Country Status (10)

Country Link
EP (1) EP1067938A1 (en)
JP (1) JP2002507570A (en)
AP (1) AP2000001926A0 (en)
AU (1) AU2742799A (en)
BR (1) BR9909153A (en)
CA (1) CA2325879A1 (en)
IT (1) ITTO980264A1 (en)
OA (1) OA11491A (en)
WO (1) WO1999048501A1 (en)
ZA (1) ZA200006020B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812199A1 (en) * 2000-07-31 2002-02-01 Maximun Frederic Yanze Effervescent antimalarial compositions containing chloroquine, optionally other active agents, effervescent couple and taste modifiers, is dissolved in water to give a pleasant tasting solution for oral administration
EP1491197A1 (en) * 2003-06-26 2004-12-29 Bertelli Motta, Guiseppe Pharmaceutical composition comprising voacamine for the stimulation and modulation of the human immunologic system
US20070232588A1 (en) * 2004-09-15 2007-10-04 Leonard Stella Anti-parasitic and/or anti-viral and/or anti-microbial compositions
US20070032460A1 (en) * 2005-08-04 2007-02-08 Leonard Stella Use of voacamine and related compounds in the treatment of malaria
CA2624750C (en) 2005-10-04 2012-01-03 The Director General, Defence Research And Development Organisation Anti-malarial compound isolated from gomphostemma niveum
EP1958638A1 (en) 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans to increase nail growth rate
WO2013081374A1 (en) 2011-11-28 2013-06-06 연세대학교 산학협력단 Pharmaceutical composition for inhibiting angiogenesis containing plant-derived natural compound
WO2014098877A1 (en) * 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
AU2020259406A1 (en) 2019-04-17 2021-11-04 Compass Pathfinder Limited Treatment of depression and other various disorders with psilocybin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2823204A (en) * 1956-03-30 1958-02-11 Gobey Lab Alkaloids of voacanga

Also Published As

Publication number Publication date
AP2000001926A0 (en) 2000-09-30
JP2002507570A (en) 2002-03-12
WO1999048501A9 (en) 2000-03-16
EP1067938A1 (en) 2001-01-17
AU2742799A (en) 1999-10-18
ITTO980264A1 (en) 1999-09-26
CA2325879A1 (en) 1999-09-30
OA11491A (en) 2004-05-07
ZA200006020B (en) 2001-06-25
WO1999048501A1 (en) 1999-09-30

Similar Documents

Publication Publication Date Title
BR9911724A (en) Cyclosporine that has an improved activity profile
BR0112054A (en) Micelle-forming composition, and methods for administration and protection of a therapeutic agent
BR0015188A (en) Pharmaceutical compositions
BR9909153A (en) Voacamine as an antimalarial agent, and antimalarial agent that contains voacamine
BR0006675A (en) Antiviral indoloxoacetyl piperazine derivatives
BR0007147A (en) Composition of tension containing gemini and co-amphiphil tension, its preparation and application
BRPI9811803B8 (en) fast-dissolving improved multiparticulate tablet
BR0109943A (en) Pharmaceutical Compositions
PT1073470E (en) Pharmaceutical compositions containing active compounds capable of improving the absorption of active ingredients
DE50202328D1 (en) AMIDOFUNCTIONAL AMINOPOLYDIORGANOSILOXANE
BR9611802A (en) Pharmaceutical compositions
BR0108210A (en) Vaccine against human immunodeficiency virus
MY130441A (en) Solutions containing epinastin
AR021578A1 (en) FORMULATION IN PRAVASTATIN PEARLS WITH ENTERIC COATING
TWI257869B (en) Skin external composition for improving moisturing effect and skin roughness
DE69614149D1 (en) Quinoline derivatives as antimalarial agents
PT1425005E (en) PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS LUMIRACOXIB
WO2002032425A3 (en) Stable oral formulation containing benzimidazole derivative
GB2363571A (en) Brassica extracts or sulforaphane in combination with reseratol as antitumor agents
BR0116205A (en) Antimicrobial 2-pyridones, their compositions and uses
HUP0202324A2 (en) Prucalopride oral solution
BR0010699A (en) Substituted benzimidazoles, their production and use as an agent against parasitic protozoa
DK1171108T3 (en) Combination preparation for the treatment of malaria
IT1306147B1 (en) DERIVATIVES OF ACTIVE INGREDIENTS FOR THERAPEUTIC AND / OR NUTRITIONAL ACTIVITIES AND COMPOSITIONS SUITABLE FOR ORAL ADMINISTRATION CONTAINING SUCH
PT1411956E (en) UTILIZATION OF OVER-SULPHATED POLYNOSTAKERS AS HIV INHIBITORS

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]